Your browser doesn't support javascript.
loading
Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety.
Honig, Stanton; Gittelman, Marc; Kaminetsky, Jed; Wang, Christina; Amory, John K; Rohowsky, Nestor; Dudley, Robert E; Woun Seo, B; Newmark, Jay; Swerdloff, Ronald.
  • Honig S; Department of Urology, Yale School of Medicine, New Haven, CT, USA. Electronic address: Stanton.honig@yale.edu.
  • Gittelman M; UroMedix and South Florida Medical Research, Aventura, FL, USA.
  • Kaminetsky J; Department of Urology, New York University School of Medicine, New York, NY, USA.
  • Wang C; The Lundquist Institute at Harbor-UCLA, Torrance, CA, USA.
  • Amory JK; Divison of Endocrinology, University of Washington School of Medicine, Seattle, WA, USA.
  • Rohowsky N; Integrated Data Consultation Services, Inc., La Grange, IL, USA.
  • Dudley RE; Clarus Therapeutics, Northbrook, IL, USA.
  • Woun Seo B; Clarus Therapeutics, Northbrook, IL, USA.
  • Newmark J; Clarus Therapeutics, Northbrook, IL, USA.
  • Swerdloff R; The Lundquist Institute at Harbor-UCLA, Torrance, CA, USA.
J Sex Med ; 19(12): 1750-1758, 2022 12.
Article en En | MEDLINE | ID: mdl-36272969

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Erección Peniana / Hipogonadismo Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Erección Peniana / Hipogonadismo Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article